Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision medicine for cervical cancer.

Current opinion in obstetrics & gynecology - 1 Feb 2022

Manrriquez Erica N, Zakhour Mae, Salani Ritu

Abstract excerpt

PURPOSE OF REVIEW: To summarize the data on precision medicine for cervical cancer including the use of potential biomarkers. We also review ongoing areas of research in cervical cancer therapeutics. RECENT FINDINGS: In the current clinical practice, programmed death ligand 1 (PD-L1) expression is used to select patients with cervical cancer for treatment with checkpoint inhibitors. However, more recently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Biomarkers, Tumor
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 34596094
DOI: 10.1097/GCO.0000000000000755

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision medicine for cervical cancer.PMID 34596094Read ↗

Polo like kinase 1 expression in cervical cancer tissues generated from multiple detection methodsSemantic proximity Read ↗

Molecular profiling of cervical neoplasia.Semantic proximity Read ↗

The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.Semantic proximity Read ↗

PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker PotentialSemantic proximity Read ↗

Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.Semantic proximity Read ↗

Integrated genomic and molecular characterization of cervical cancer.Semantic proximity Read ↗

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.Semantic proximity Read ↗

Genomic characterisation of cervical cancer and human papillomavirus: new opportunities for precision medicine.Semantic proximity Read ↗

Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancerSemantic proximity Read ↗

Cervical Carcinoma: Oncobiology and BiomarkersSemantic proximity Read ↗

Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNASemantic proximity Read ↗

Molecular biology of cervical cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.